Mortality in spondylarthritis

Joint Bone Spine

Volumn 78, Issue 5, 2011, Pages 466-470

  Prati, Clément ^a   Claudepierre, Pascal ^b,d   Pham, Thao ^c   Wendling, Daniel ^a  

^a UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^b HENRI MONDOR HOSPITAL   (France)

^c HÔPITAL DE LA CONCEPTION   (France)

^d UNIVERSITÉ PARIS EST CRÉTEIL   (France)

Author keywords

Ankylosing spondylitis; Cancer; Cardiovascular disease; Mortality

Indexed keywords

ADALIMUMAB; ETANERCEPT; INFLIXIMAB; NONSTEROID ANTIINFLAMMATORY AGENT; RADIUM 224; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ANKYLOSING SPONDYLITIS; BONE TUMOR; CANCER MORTALITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUSE OF DEATH; HIP ARTHROPLASTY; HUMAN; INJURY; KIDNEY DISEASE; LOW DRUG DOSE; LUNG COMPLICATION; LYMPHATIC LEUKEMIA; MORTALITY; MYELOID LEUKEMIA; NEOPLASM; OSTEOTOMY; POLYARTHRITIS; RADIOTHERAPY; RHEUMATOID ARTHRITIS; SHORT SURVEY; SIDE EFFECT; SPINAL RADIOTHERAPY; SPINE SURGERY; SURGICAL MORTALITY; SURVIVAL RATE; VERTEBRA DISLOCATION; VERTEBRA FRACTURE;

CARDIOVASCULAR DISEASES; COMORBIDITY; HUMANS; NEOPLASMS; RISK FACTORS; SPONDYLITIS, ANKYLOSING;

EID: 80053448845     PISSN: 1297319X     EISSN: 17787254     Source Type: Journal    
DOI: 10.1016/j.jbspin.2011.02.012     Document Type: Short Survey

References (46)

1. Zochling J., Braun J. Mortality in ankylosing spondylitis. Clin Exp Rheumatol 2008, 26:S80-S84.
2. Braun J., Pincus T. Mortality, course of disease and prognosis of patients with ankylosing spondylitis. Clin Exp Rheumatol 2002, 20:S16-S22.
3. Court-Brown W.M., Doll R. Leukaemia and aplastic anaemia in patients irradiated for ankylosing spondylitis. Spec Rep Ser Med Res Counc (GB) 1957, 295:1-135.
4. Radford E.P., Doll R., Smith P.G. Mortality among patients with ankylosing spondylitis not given X-ray therapy. N Engl J Med 1977, 297:572-576.
5. Lehtinen K. Mortality and causes of death in 398 patients admitted to hospital with ankylosing spondylitis. Ann Rheum Dis 1993, 52:174-176.
6. Kaprove R.E., Little A.H., Graham D.C., et al. Ankylosing spondylitis: survival in men with and without radiotherapy. Arthritis Rheum 1980, 23:57-61.
7. Khan M.A., Khan M.K., Kushner I. Survival among patients with ankylosing spondylitis: a life-table analysis. J Rheumatol 1981, 8:86-90.
8. Weiss H.A., Darby S.C., Doll R. Cancer mortality following X-ray treatment for ankylosing spondylitis. Int J Cancer 1994, 59:327-338.
9. Carbone L.D., Cooper C., Michet C.J., et al. Ankylosing spondylitis in Rochester, Minnesota, 1935-1989. Is the epidemiology changing?. Arthritis Rheum 1992, 35:1476-1482.
10. Bakland G., Nossent H.C., Gran J.T. Incidence and prevalence of ankylosing spondylitis in Northern Norway. Arthritis Rheum 2005, 53:850-855.
11. Haskard D.O. Accelerated atherosclerosis in inflammatory rheumatic diseases. Scand J Rheumatol 2004, 33:281-292.
12. Divecha H., Sattar N., Rumley A., et al. Cardiovascular risk parameters in men with ankylosing spondylitis in comparison with non-inflammatory control subjects: relevance of systemic inflammation. Clin Sci (Lond) 2005, 109:171-176.
13. Gonzalez-Lopez L., Sanchez-Hernandez J.D., Aguilar-Chavez E.A., et al. Hyperhomocysteinemia in ankylosing spondylitis: prevalence and association with clinical variables. Rheumatol Int 2008, 28:1223-1228.
14. Peters M.J., van Eijk I.C., Smulders Y.M., et al. Signs of accelerated preclinical atherosclerosis in patients with ankylosing spondylitis. J Rheumatol 2010, 37:161-166.
15. Sari I., Okan T., Akar S., et al. Impaired endothelial function in patients with ankylosing spondylitis. Rheumatology (Oxford) 2006, 45:283-286.
16. Mathieu S., Gossec L., Pavy S., et al. Myocardial infarction and cardiovascular risk profile in ankylosing spondylitis. A systematic review and meta-analysis. Ann Rheum Dis 2010, 69:105.
17. Hürlimann D., Forster A., Noll G., et al. Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis. Circulation 2002, 106:2184-2187.
18. Mathieu S., Dubost J.J., Tournadre A., et al. Effects of 14weeks of TNF alpha blockade treatment on lipid profile in ankylosing spondylitis. Joint Bone Spine 2010, 77:50-52.
19. Goodson N.J., Brookhart A.M., Symmons D.P., et al. Non-steroidal anti-inflammatory drug use does not appear to be associated with increased cardiovascular mortality in patients with inflammatory polyarthritis: results from a primary care based inception cohort of patients. Ann Rheum Dis 2009, 68:367-372.
20. Vinsonneau U., Brondex A., Mansourati J., et al. Cardiovascular disease in patients with spondyloarthropathies. Joint Bone Spine 2008, 75:18-21.
21. Stamato T., Laxer R.M., de Freitas C., et al. Prevalence of cardiac manifestations of juvenile ankylosing spondylitis. Am J Cardiol 1995, 75:744-746.
22. Bergfeldt L., Allebeck P., Edhag O. Mortality in pacemaker-treated patients. A follow-up study of the impact of HLA B27 and associated rheumatic disorders. Acta Med Scand 1987, 222:293-299.
23. Askling J., Klareskog L., Blomqvist P., et al. Risk for malignant lymphoma in ankylosing spondylitis: a nationwide Swedish case-control study. Ann Rheum Dis 2006, 65:1184-1187.
24. Feltelius N., Ekbom A., Blomqvist P. Cancer incidence among patients with ankylosing spondylitis in Sweden 1965-95: a population based cohort study. Ann Rheum Dis 2003, 62:1185-1188.
25. Nannini C., Cantini F., Niccoli L., et al. Single-center series and systematic review of randomized controlled trials of malignancies in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis receiving anti-tumor necrosis factor alpha therapy: is there a need for more comprehensive screening procedures?. Arthritis Rheum 2009, 61:801-812.
26. Westerveld L.A., Verlaan J.J., Oner F.C. Spinal fractures in patients with ankylosing spinal disorders: a systematic review of the literature on treatment, neurological status and complications. Eur Spine J 2009, 18:145-156.
27. Verlaan J.J., Diekerhof C.H., Buskens E., et al. Surgical treatment of traumatic fractures of the thoracic and lumbar spine: a systematic review of the literature on techniques, complications, and outcome. Spine (Phila Pa 1976) 2004, 29:803-814.
28. Strobel E.S., Fritschka E. Case report and review of the literature. Fatal pulmonary complication in ankylosing spondylitis. Clin Rheumatol 1997, 16:617-622.
29. Rosenow E., Strimlan C.V., Muhm J.R., et al. Pleuropulmonary manifestations of ankylosing spondylitis. Mayo Clin Proc 1977, 52:641-649.
30. Sampaio-Barros P.D., Cerqueira E.M., Rezende S.M., et al. Pulmonary involvement in ankylosing spondylitis. Clin Rheumatol 2007, 26:225-230.
31. Myllykangas-Luosujärvi R., Aho K., Lehtinen K., et al. Increased incidence of alcohol-related deaths from accidents and violence in subjects with ankylosing spondylitis. Br J Rheumatol 1998, 37:688-690.
32. Strobel E.S., Fritschka E. Renal diseases in ankylosing spondylitis: review of the literature illustrated by case reports. Clin Rheumatol 1998, 17:524-530.
33. Immonen K., Finne P., Hakala M., et al. No improvement in survival of patients with amyloidosis associated with inflammatory rheumatic diseases - data from the Finnish national registry for kidney diseases. J Rheumatol 2008, 35:1334-1338.
34. Gratacos J., Orellana C., Sanmarti R., et al. Secondary amyloidosis in ankylosing spondylitis. A systematic survey of 137 patients using abdominal fat aspiration. J Rheumatol 1997, 24:912-915.
35. Lehtinen K. The mortality and causes of death of patients with "hypergamma type" of ankylosing spondylitis. Scand J Rheumatol 1983, 12:3-4.
36. McMaster M.J. Osteotomy of the cervical spine in ankylosing spondylitis. Bone Joint Surg Br 1997, 79:197-203.
37. Etame A.B., Than K.D., Wang A.C., et al. Surgical management of symptomatic cervical or cervicothoracic kyphosis due to ankylosing spondylitis. Spine (Phila Pa 1976) 2008, 33:E559-E564.
38. Van Royen B.J., De Gast A. Lumbar osteotomy for correction of thoracolumbar kyphotic deformity in ankylosing spondylitis. A structured review of three methods of treatment. Ann Rheum Dis 1999, 58:399-406.
39. Sochart D.H., Porter M.L. Long-term results of total hip replacement in young patients who had ankylosing spondylitis. Eighteen to thirty-year results with survivorship analysis. J Bone Joint Surg Am 1997, 79:1181-1189.
40. Weiss H.A., Darby S.C., Fearn T., et al. Leukemia mortality after X-ray treatment for ankylosing spondylitis. Radiat Res 1995, 142:1-11.
41. Darby S.C., Doll R., Gill S.K., et al. Long term mortality after a single treatment course with X-rays in patients treated for ankylosing spondylitis. Br J Cancer 1987, 55:179-190.
42. Smith P.G., Doll R. Mortality among patients with ankylosing spondylitis after a single treatment course with x rays. Br Med J (Clin Res Ed) 1982, 284:449-460.
43. Smith P.G., Doll R., Radford E.P. Cancer mortality among patients with ankylosing spondylitis not given X-ray therapy. Br J Radiol 1977, 50:728-734.
44. Brown W.M., Doll R. Mortality from cancer and other causes after radiotherapy for ankylosing spondylitis. Br Med J 1965, 2:1327-1332.
45. Wick R.R., Gössner W. Follow-up study of late effects in 224Ra treated ankylosing spondylitis patients. Health Phys 1983, 44:187-195.
46. Wilkinson M., Bywaters E.G. Clinical features and course of ankylosing spondylitis; as seen in a follow-up of 222 hospital referred cases. Ann Rheum Dis 1958, 17:209-228.